Eli Lilly, the American pharmaceutical company headquartered in Indianapolis, Indiana, said it would expand its headquarters outside of its home state. The decision was mainly due to the abortion law that was recently signed in the territory.
On Friday, Aug. 5, the state’s Gov. Eric Holcomb, signed Senate Bill 1, which officially made the policy a law in the state. This policy prohibits abortions in Indiana, at any stage and only exempts mothers whose lives are at risk.
In some cases of incest, rape, or fetal anomalies, abortion could also be allowed. As per Fox Business, Eli Lilly’s move to expand its headquarters outside of its home state is its response to the abortion ban. The new Bill has been signed following the overturning of the 1973 Roe v. Wade policy which was a landmark decision of the U.S. Supreme Court where the Court ruled that the Constitution of the United States presents the right to have an abortion.
"As a global company headquartered in Indianapolis for more than 145 years, we work hard to retain and attract thousands of people who are important drivers of our state’s economy,” the company said in a statement obtained by Fox News last weekend. “Given this new law, we will be forced to plan for more employment growth outside our home state."
Eli Lilly added, 'We will be forced to plan for more employment growth outside our home state.”
It was reported that the pharmaceutical company was criticized by the White House as well as its fellow Indiana-based company, Cummins, for the move. On the other hand, the Republicans are said to have welcomed and celebrated the signing of the new law. Indiana state Rep. Wendy McNamara said that this just made Indiana "one of the most pro-life states in the nation."
The new anti-abortion bill is set to take effect in Indiana on Sept. 15. At any rate, the White House’s press secretary released a statement following the signing of the bill, and it apparently strongly condemned the move. Through the White House Press Secretary Karine Jean-Pierre, the Biden administration described the implementation of the law as a “devastating step.”
“And it is another radical step by Republican legislators to take away women’s reproductive rights and freedom, and put personal health-care decisions in the hands of politicians rather than women and their doctors,” Jean-Pierre said in a statement.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Thailand Inflation Remains Negative for 10th Straight Month in January
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 



